angiotensin ii has been researched along with Arteriosclerosis in 214 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (17.29) | 18.7374 |
| 1990's | 53 (24.77) | 18.2507 |
| 2000's | 121 (56.54) | 29.6817 |
| 2010's | 3 (1.40) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schindler, C | 1 |
| Siragy, HM | 1 |
| CHEN, J; DENG, G; JIN, H; JU, SH; WANG, ZJ; WEN, S; YAO, YY; ZHAO, R | 1 |
| Han, CJ; Li, M; Liu, JT | 1 |
| Goto, S; Hirose, Y; Miyazaki, H; Nishijima, F; Niwa, T; Shimizu, H; Zghonda, N; Zrelli, H | 1 |
| Mansoor, GA; Thavarajah, S | 1 |
| Dell'Italia, LJ; Husain, A | 1 |
| Brasier, AR; Eledrisi, MS; Recinos, A | 1 |
| Chen, R; Hamada, M; Hiwada, K; Horiuchi, M; Iwai, M; Nakagami, H; Sugaya, T; Suzuki, J; Wu, L | 1 |
| Benedict, CR; Katagiri, T; Koba, S; Pakala, R; Watanabe, T | 1 |
| Ariff, B; Augst, A; Barratt, D; Glor, F; Hughes, A; Poulter, N; Sever, P; Stanton, A; Thom, SA; Xu, Y | 1 |
| Ferrario, CM; Strawn, WB | 1 |
| Guski, H; Persson, PB; Stauss, HM; Wilfert, K | 1 |
| Dole, W; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Tham, DM; Vergona, R; Wang, YX; Wilson, DW | 1 |
| Athanassious, CN; Da Cunha, V; Martin-McNulty, B; Powers, AF; Rutledge, JC; Sullivan, ME; Tham, DM; Wang, YX; Wilson, DW | 1 |
| Miyazaki, M; Takai, S | 3 |
| Schiffrin, EL; Virdis, A | 1 |
| Carmeliet, P; Deng, GG; Dole, WP; Freay, A; Halks-Miller, M; Loskutoff, DJ; Martin-McNulty, B; Sukovich, DA; Thinnes, T; Wang, YX | 1 |
| Siegel-Axel, DI | 1 |
| Cassis, LA; Daugherty, A; Manning, MW | 3 |
| Jacoby, DS; Rader, DJ | 1 |
| Galle, J; Seibold, S; Wanner, C | 1 |
| Rutledge, JC; Tham, DM; Wang, YX | 1 |
| Ivanoviene, L; Lesauskaite, V; Valanciūte, A | 1 |
| Babamusta, F; Cassis, LA; Daugherty, A; Saraff, K | 1 |
| Cathcart, MK | 1 |
| Arias-Magallona, S; Blaschke, F; Bruemmer, D; Collins, AR; Fishbein, MC; Graf, K; Hsueh, WA; Kintscher, U; Law, RE; Noh, G; Territo, M; Wang, W | 1 |
| Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Kitamoto, S; Ni, W; Nishida, K; Takeshita, A; Usui, M; Zhao, Q | 1 |
| Kintscher, U; Law, RE; Lyon, CJ | 1 |
| Galle, J | 1 |
| Ferro, A; Hurairah, H | 1 |
| Jabs, K; Kon, V | 1 |
| Cassis, LA; D'Souza, SS; Daugherty, A; Henriques, TA; Huang, J | 1 |
| Cassis, L; Daugherty, A | 2 |
| Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E | 1 |
| Michel, JB | 2 |
| Golledge, J; Karan, M; Lam, A; Mangan, S; McCann, M | 1 |
| Kawata, H | 1 |
| Iwasaka, T; Okigaki, M | 1 |
| Makino, H; Nakamura, Y | 1 |
| Hirata, Y | 1 |
| Ito, S | 1 |
| Egashira, K; Hirouchi, Y; Inoue, S; Kitajima, S; Kitamoto, S; Kohjimoto, Y; Nakano, K; Usui, M | 1 |
| Aubert, JF; Bouzourene, K; Brunner, HR; Duchosal, MA; Gabbiani, G; Hao, H; Hayoz, D; Korber, M; Mazzolai, L; Nussberger, J; Vallet, V | 1 |
| Mallat, Z; Tedgui, A | 1 |
| Fitch, RM; Wang, YX | 1 |
| Charo, IF; Egashira, K; Hiasa, K; Ihara, Y; Ishibashi, M; Kura, S; Ohtani, K; Sunagawa, K; Takeshita, A; Tsuzuki, T; Zhao, Q | 1 |
| Babaev, VR; Fazio, S; Fogo, A; Ichikawa, I; Kon, V; Linton, MF; Nobuhiko, A; Suganuma, E; Swift, LL | 1 |
| Fujioka, S; Hamada, J; Hasegawa, Y; Hashiguchi, A; Kai, Y; Miura, M; Morioka, M; Todaka, T; Ushio, Y; Yano, S | 1 |
| Glass, CK; Ogawa, S | 1 |
| AbdAlla, S; el Faramawy, Y; Langer, A; Lother, H; Quitterer, U | 1 |
| Ding, J; Du, RZ; Ge, JB; Huang, GZ; Jiang, JF; Liang, C; Wu, ZG | 1 |
| Badia, E; Carbonneau, MA; Fouret, G; Grimaldi, P; Lauret, C; Léger, CL; Oliveira, MV | 1 |
| da Cunha, V; Deng, G; Ho, JJ; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Tham, DM; Vergona, R; Wang, YX; Wilson, DW | 1 |
| Cassis, LA; Daugherty, A; Inagami, T; Lu, H; Rateri, DL | 1 |
| Wang, YX | 1 |
| Cassis, LA; Daugherty, A; Helton, MJ; Howatt, DA; King, VL | 1 |
| Ferrannini, E; Santini, E; Solini, A | 1 |
| Raij, L; Schulman, IH; Zhou, MS | 1 |
| Thomas, WG | 1 |
| Burnier, M; Maillard, M; Meier, P | 1 |
| Horiuchi, M; Ide, A; Iwai, M; Li, HS; Li, JM; Min, LJ; Mogi, M; Okumura, M; Suzuki, H; Suzuki, J; Tsuda, M | 1 |
| Imanishi, M; Konishi, Y; Miyazaki, M; Morikawa, T; Okada, N; Okumura, M; Suzuki, H; Takai, S; Yoshioka, K | 1 |
| Higaki, J; Okura, T | 1 |
| Catanzaro, DF; Catanzaro, SE; Chen, R; Dansky, HM; Hu, L; Zhou, Y | 1 |
| Dwarakanath, RS; Lanting, L; Natarajan, R; Reddy, MA; Sahar, S; Todorov, I | 1 |
| Dechaux, M; Drueke, TB; Ivanovski, O; Lacour, B; Massy, ZA; Mothu, N; Muntzel, M; Nguyen-Khoa, T; Phan, O; Szumilak, D | 1 |
| Pool, JL | 1 |
| Ito, T; Katano, Y; Kubota, I; Shishido, T; Takasaki, S; Takeishi, Y; Tasaki, K; Tomoike, H; Wakabayashi, I | 1 |
| Kintscher, U; Unger, T | 1 |
| Bergström, G; Fitzgerald, SM; Gan, LM; Johansson, ME; Wickman, A | 1 |
| Blanco-Colio, LM; Egido, J; Martín-Ventura, JL; Muñoz-García, B; Ruiz-Ortega, M | 1 |
| Bhowmick, NA; Bottinger, EP; Canlas, E; Deng, C; Huang, XR; Ju, W; Lan, HY; Oka, K; Truong, LD; Wang, W | 1 |
| Garaliene, V | 1 |
| Cai, W; Chen, JZ; Ruan, LM; Wang, YN | 1 |
| Miyazaki, M | 1 |
| Egashira, K; Ihara, Y | 1 |
| Kurabayashi, M | 1 |
| Kim-Mitsuyama, S | 1 |
| Sata, M | 1 |
| Matsubara, H; Tsubakimoto, Y; Yamada, H; Yokoi, H | 1 |
| Abe, S; Ideishi, M; Inoue, Y; Murakami, K; Saku, K; Uehara, Y; Urata, H | 1 |
| Mitsuyama, K | 1 |
| Tarazi, RC | 1 |
| Stanley, JC; Whitehouse, WM | 1 |
| Felton, KR; Gorkin, JU; Krakoff, LR; Ribeiro, AB | 1 |
| Bonomini, V; Feletti, C; Scolari, MP; Stefoni, S; Vangelista, A | 1 |
| Constantinides, P | 2 |
| Angell-James, JE; George, MJ; Peters, CJ | 1 |
| Itoh, H; Nakao, K | 1 |
| de Lasson, L; Hansen, HE; Juhl, B; Paaske, WP; Pedersen, EB | 1 |
| Pavan, E; Pessina, AC; Rossi, A; Rossi, G; Sacchetto, A | 1 |
| Hiramori, K; Makita, S; Nakamura, M; Yoshida, H | 1 |
| Gohlke, P; Linz, W; Schölkens, BA; Unger, T; Wiemer, G | 1 |
| Pessina, AC; Rossi, G | 1 |
| McInnes, GT | 1 |
| Gmiński, J; Stajszczyk, M | 2 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 2 |
| Becker, CH; Kindling, PH; Matthias, D; Riezler, R | 1 |
| Berliner, JA; Kim, JA; Nadler, JL | 1 |
| Doba, N; Hinohara, S; Kihara, Y; Tomiyama, H; Watanabe, G; Yoshida, H | 1 |
| Dusting, GJ; Hickey, H; Hyland, R; Makdissi, M; Wilks, D | 1 |
| Murakami, T; Yamada, N | 1 |
| Ikram, H | 1 |
| Makino, N; Sugano, M; Yanaga, T | 1 |
| García Fuentes, M; González-Lamuño, D; Lozano, MJ | 1 |
| Riegger, GA | 1 |
| Aoki, K; Hori, M; Hoshida, S; Igarashi, J; Kuzuya, T; Nishida, M; Tada, M; Yamashita, N | 1 |
| Kobayashi, S; Matsumura, E; Miyazaki, M; Shiota, N; Takai, S | 1 |
| Lavie, CJ; Malik, FS; Mehra, MR; Milani, RV; Re, RN | 1 |
| Marci, M; Raffa, S; Russo, F | 1 |
| Locher, R; Suter, PM; Vetter, W; Weyhenmeyer, R | 1 |
| Lüscher, TF; Noll, G; Ruschitzka, FT | 1 |
| Keidar, S | 1 |
| Miagkova, MA; Pogozheva, AV; Rozanova, IA; Savitskaia, IuA | 1 |
| Heistad, DD; Potter, DD; Rossen, JD; Sobey, CG; Tompkins, PK | 1 |
| Mehta, JL; Mehta, P; Meng, H; Mohuczy, D; Phillips, MI; Shen, L; Yang, BC | 1 |
| Fukamizu, A | 1 |
| Gibbons, GH | 1 |
| Pepine, CJ | 1 |
| Cole, SA; Hixson, JE | 1 |
| Herdegen, T; Kreuzer, J; Kübler, K; Loebe, M; Watson, L; Wende, P | 1 |
| Browatzki, M; Kranzhöfer, R; Kübler, W; Schmidt, J | 1 |
| Arakawa, K; Ideishi, M; Ihara, M; Kikuchi, M; Kinoshita, A; Sasaguri, M; Suzumiya, J; Urata, H | 1 |
| Kimura, R; Matsuura, N; Miyake, H; Nozawa, Y; Yamada, S | 1 |
| Hagl, S; Kranzhöfer, R; Kübler, W; Libby, P; Pfeiffer, CA; Schmidt, J | 1 |
| Fennessy, PA; Higaki, J; Moriguchi, K; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Takiuchi, S; Yanagitani, Y | 1 |
| Moorhead, JF; Powis, SH; Ruan, XZ; Varghese, Z | 1 |
| Lippert, TH; Mueck, AO; Seeger, H | 1 |
| Alexander, RW; Chen, XL; Hammes, CP; Harrison, DG; Laursen, JB; Medford, RM; Sundell, CL; Tummala, PE | 1 |
| Miyazaki, M; Sakonjo, H; Takai, S | 1 |
| Attias, J; Aviram, M; Coleman, R; Heinrich, R; Keidar, S | 1 |
| Chen, YL; Hung, LS; Jiang, MJ; Lee, YM; Yu, YJ | 1 |
| Arakawa, K; Ideishi, M; Kimura, M; Sakata, N; Sasaguri, M; Tashiro, T; Uehara, Y; Urata, H | 1 |
| Drischel, K; Guski, H; Persson, PB; Stauss, HM; Unbehaun, A; Wilfert, K | 1 |
| Linz, W; Malinski, T; Schölkens, BA; Wiemer, G; Wohlfart, P | 1 |
| Ellahham, S; Mincemoyer, R; Panza, JA; Prasad, A; Quyyumi, AA; Schenke, WH; Tupas-Habib, T; Waclawin, MA | 1 |
| Dimmeler, S; Zeiher, AM | 1 |
| Berk, BC; Haendeler, J; Sottile, J | 1 |
| Aviram, M; Hayek, T; Heinrich, R; Keidar, S; Sakhnini, E | 1 |
| de La Sierra, A; Ruilope, LM | 1 |
| Kagiyama, S; Phillips, MI; Schmidt-Ott, KM | 1 |
| Arakawa, K; Urata, H | 1 |
| Airoldi, F; Alberti, C; Bencini, C; Benti, R; Gerundini, P; Longari, V; Lovaria, A; Marana, I; Morganti, A; Nador, B; Nicolini, A; Palatresi, S | 1 |
| Kools, JJ; Taylor, WR; Weiss, D | 1 |
| Aronov, DM | 1 |
| Katovich, MJ; Pachori, A | 1 |
| Fleck, E; Hsueh, WA; Kim, S; Kintscher, U; Law, RE; Wakino, S | 1 |
| Fujita, T | 1 |
| Sorescu, D; Taylor, WR; Weiss, D | 1 |
| Chen, HJ; Li, DY; Mehta, JL; Phillips, MI; Saldeen, T | 1 |
| Luft, FC | 1 |
| Aikawa, M; Hill, CC; Lee, RT; Libby, P; Sakamoto, H; Taylor, WR; Weiss, D | 1 |
| Davydov, AA; Miagkova, MA; Pogozheva, AV | 1 |
| Fischer, JW; Hahn, AW; Stoll, M; Unger, T | 1 |
| Choy, JC; Granville, DJ; Hunt, DW; McManus, BM | 1 |
| Aviram, M; Hayek, T; Heinrich, R; Kaplan, M; Keidar, S | 1 |
| Galle, J; Quaschning, T | 1 |
| Harrison, DG; Nickenig, G | 1 |
| Ferrario, CM; Levy, P; Smith, R; Strawn, W | 1 |
| Weber, MA | 1 |
| Ferrario, CM | 1 |
| Unger, T | 1 |
| Chen, H; Li, D; Mehta, JL | 1 |
| Dean, RH; Ferrario, CM; Strawn, WB | 1 |
| Davidson, J; Rotondo, D | 1 |
| Chikara, S; Fukuda, N; Hu, WY; Kanmatsuse, K; Kishioka, H; Nakayama, M; Teng, J | 1 |
| Chayama, K; Higashi, Y; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S | 1 |
| Kagiyama, S; Phillips, MI | 1 |
| Drexler, H; Fuchs, M; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Lichtenberg, A; Rothkötter, HJ; Schieffer, B | 1 |
| Sulek, K | 1 |
| Hollander, W | 1 |
| Shimamoto, T | 2 |
| McGiff, JC | 1 |
| Adam, WE; Arlart, IP; Franz, HE; Nobbe, F; Rosenthal, J; Wagner, H | 1 |
| Linss, G; Schmidt, PK | 1 |
| Cottier, P | 1 |
| Ball, SG | 1 |
| Dusting, GJ; Mendelsohn, FA; Richardson, K; Zambetis-Bellesis, M | 1 |
| Bühler, FR; Hahn, AW; Resink, TJ; Scott-Burden, T | 1 |
| Faraci, FM; Heistad, DD | 1 |
| Hof, A; Hof, RP | 1 |
| Dzau, VJ; Safar, ME | 1 |
| Dahn, I; Hallböök, T; Larsen, OA; Lassen, NA; Nilsén, R; Sorensen, AW; Westling, H | 1 |
| Freis, ED; Heath, WC; Luchsinger, PC; Snell, RE | 1 |
| Brest, AN | 1 |
| Mertz, DP; Sarre, H | 1 |
| Barold, SS; Hildner, FJ; Linhart, JW; Samet, P | 1 |
| Baumann, K; Endres, P; Gysling, E; Rubli, H; Schönbeck, M; Siegenthaler, W; Weidmann, P; Werning, C | 1 |
| Berg, G; Bron, K; Misage, JR; Moutsos, SE; Perez-Stable, E; Scheib, ET; Shapiro, AP | 1 |
| Mullane, JF | 1 |
| Kedrowa, S; Stazka, Z | 1 |
| Gillespie, JA; Kane, SP | 1 |
| Ahlström, H; Westling, H | 1 |
| Tareev, EM | 1 |
| Page, IH | 2 |
| Eigler, FW | 1 |
| Horwitz, LD; Mullins, CB; Payne, RM | 1 |
| Khairallah, PA; Robertson, AL | 1 |
| Stock, J; Wolf, G | 1 |
| Kobayashi, M; Moriya, K; Numano, F; Shimamoto, T | 1 |
| Demanet, JC; Verniory, A | 1 |
88 review(s) available for angiotensin ii and Arteriosclerosis
| Article | Year |
|---|---|
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Arteriosclerosis; Humans; Hypertension; Kidney Diseases; Nitric Oxide; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin-Angiotensin System; Vasodilation | 2009 |
[Angiotensin II-induced monocyte/macrophage inflammatory effects and drug intervention].
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Humans; Inflammation; Macrophages; Monocytes | 2011 |
Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Cardiovascular System; Diabetes Mellitus; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
Topics: Angiotensin I; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cardiovascular Diseases; Chymases; Heart Diseases; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Serine Endopeptidases | 2002 |
Vascular inflammation and the renin-angiotensin system.
Topics: Acute-Phase Proteins; Angiotensin II; Animals; Arteriosclerosis; Cholesterol, LDL; Endothelium, Vascular; Feedback, Physiological; Humans; Inflammation; Interleukin-6; Liver; Macrophages; Monocytes; Oxidation-Reduction; Reactive Oxygen Species; Renin-Angiotensin System; Signal Transduction | 2002 |
Mechanisms linking angiotensin II and atherogenesis.
Topics: Angiotensin II; Animals; Apoptosis; Arteriosclerosis; Endothelium, Vascular; Humans; Macrophages; Myocytes, Smooth Muscle; Oxidative Stress | 2002 |
[Involvement of angiotensin II in development of atherosclerosis].
Topics: Angiotensin II; Animals; Arteriosclerosis; Haplorhini; Humans | 2002 |
Vascular inflammation: a role in vascular disease in hypertension?
Topics: Angiotensin II; Arteriosclerosis; Endothelins; Endothelium, Vascular; Female; Humans; Hypertension; Inflammation Mediators; Male; Nitric Oxide; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Vascular Diseases; Vascular Endothelial Growth Factor A | 2003 |
Cerivastatin: a cellular and molecular drug for the future?
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arteriosclerosis; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Monocytes; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Pyridines; Receptors, Angiotensin; Thrombosis | 2003 |
Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Clinical Trials as Topic; Endothelium, Vascular; Growth Substances; Humans; Inflammation; Lipoproteins, LDL; Oxidative Stress; Renin-Angiotensin System; Risk Factors; Signal Transduction | 2003 |
Inflammation in uremic patients: what is the link?
Topics: Angiotensin II; Antioxidants; Arteriosclerosis; Biomarkers; Cholesterol, LDL; Humans; Inflammation; Oxidative Stress; Renal Dialysis; Risk Factors; Uremia | 2003 |
Modulation of vascular inflammation by PPARs.
Topics: Angiotensin II; Animals; Arteriosclerosis; Arteritis; Clinical Trials as Topic; Gene Expression Regulation; Humans; Macrophages; Monocytes; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2003 |
[Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Apoptosis; Arteriosclerosis; Calcium Channel Blockers; Caspases; Cholesterol; Disease Progression; Endothelium, Vascular; Humans; Hypolipidemic Agents; Macrophages; Muscle, Smooth, Vascular; Oxidative Stress | 2003 |
Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Calcium Signaling; Humans; Macrophages; Mice; Monocytes; NADPH Oxidases; Oxidative Stress; Phospholipases A; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Superoxides; Vasculitis | 2004 |
Angiotensin II, PPAR-gamma and atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Blood Vessels; Disease Models, Animal; Humans; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
[Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Arteritis; Clinical Trials as Topic; Humans; Inflammation Mediators; Lipoproteins, LDL; Oxidative Stress; Reactive Oxygen Species | 2004 |
The role of the endothelium in the control of vascular function.
Topics: Angiotensin II; Arteriosclerosis; Cardiovascular Diseases; Cell Adhesion Molecules; Coagulants; Diabetes Mellitus; Endothelin-1; Endothelium, Vascular; Female; Humans; Pre-Eclampsia; Pregnancy; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Angiotensin in atherosclerosis.
Topics: Angiotensin II; Arteriosclerosis; Diabetes Mellitus; Disease Progression; Estrogens; Humans; Hyperlipidemias; Hypertension; Inflammation; Insulin Resistance; Risk Factors | 2004 |
Angiotensin II-mediated development of vascular diseases.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Humans; Hyperlipidemias; Macrophages; Vascular Diseases | 2004 |
[Renin-angiotensin system and vascular remodelling].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Arteriosclerosis; Blood Pressure; Blood Vessels; Fibrosis; Humans; Hypertension, Renovascular; Hypertrophy; Inflammation; Models, Biological; NADPH Oxidases; Reactive Oxygen Species; Receptors, Angiotensin; Renin-Angiotensin System; Transforming Growth Factor beta | 2004 |
[Mechanism of vascular endothelial dysfunction induced by hypertension].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Endothelium, Vascular; Humans; Hypertension; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Risk Factors | 2004 |
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1 | 2004 |
[Involvement of HGF in the pathogenesis of hypertension and hypertensive target-organ damage].
Topics: Angiotensin II; Animals; Apoptosis; Arteriosclerosis; Autocrine Communication; Down-Regulation; Endothelium, Vascular; Hepatocyte Growth Factor; Humans; Hypertension; Kidney Tubules; Paracrine Communication; Transforming Growth Factor beta | 2004 |
[NO and hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation | 2004 |
[Renovascular hypertension].
Topics: Angioplasty, Balloon; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aortic Arch Syndromes; Arteriosclerosis; Diagnosis, Differential; Fibromuscular Dysplasia; Humans; Hypertension, Renovascular; Kidney Tubules, Proximal; Prognosis; Renal Artery Obstruction; Renin; Sodium; Stents | 2004 |
Vascular stiffness: measurements, mechanisms and implications.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Arteries; Arteriosclerosis; Endothelium, Vascular; Estrogens; Humans; Inflammation; Nitric Oxide; Vascular Resistance | 2004 |
[Tissue consequence of renin-angiotensin system activation].
Topics: Angiotensin II; Arteriosclerosis; Blood Coagulation; Calcium; Humans; Hypertension; Inflammation; Receptors, Cell Surface; Renin-Angiotensin System; Signal Transduction; Vacuolar Proton-Translocating ATPases; Vasoconstrictor Agents | 2004 |
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis.
Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Reactive Oxygen Species | 2005 |
The future of angiotensin II inhibition in cardiovascular medicine.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Protease Inhibitors; Renin; Risk Factors | 2005 |
[Atherosclerosis].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Humans; Mice; Oxidative Stress; Renin-Angiotensin System | 2005 |
The role of angiotensin II in hypertension and end-organ damage.
Topics: Angiotensin II; Animals; Arteriosclerosis; Coronary Disease; Diabetes Complications; Humans; Hypertension; Kidney Diseases | 2000 |
[Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Cyclooxygenase Inhibitors; Endothelium, Vascular; Haplorhini; Humans; Hypertension; Hypolipidemic Agents; Lipid Metabolism; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2005 |
[The main determinants of endothelial dysfunction].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arteriosclerosis; Biological Availability; Diabetes Mellitus; Endothelium, Vascular; Free Radicals; Heart Failure; Homocysteine; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Potassium Channels; Reactive Oxygen Species; Renal Insufficiency; Risk Factors; Vasodilation | 2006 |
[Tissue angiotensin II generating system].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriosclerosis; Chymases; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases | 2006 |
[AII and inflammation].
Topics: Angiotensin II; Animals; Arteriosclerosis; Capillary Permeability; Cell Adhesion Molecules; Cytokines; Humans; Inflammation; Inflammation Mediators; Leukocytes; NF-kappa B; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Transcription, Genetic | 2006 |
[Oxidative stress].
Topics: Angiotensin II; Arteriosclerosis; Humans; Hypertension; Inflammation; Lipoproteins, LDL; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Risk Factors | 2006 |
[Protective effect of ARB on vascular diseases].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriosclerosis; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; MAP Kinase Kinase Kinase 5; Nitric Oxide; Oxidative Stress | 2006 |
[Anti-atherosclerotic effect].
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Drug Therapy, Combination; Humans; Mineralocorticoid Receptor Antagonists; Receptors, Angiotensin | 2006 |
[Apoptosis of vascular cells].
Topics: Angiotensin II; Antioxidants; Apoptosis; Arteriosclerosis; Endothelium, Vascular; Estrogens; fas Receptor; Growth Substances; Humans; Hypertension; Lipopolysaccharides; Lipoproteins, LDL; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Stress, Mechanical; Tumor Necrosis Factor-alpha | 2006 |
[Pathophysiological significance of RAS in formation of arteriosclerosis].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriosclerosis; Bone Marrow Cells; Endothelium, Vascular; Humans; Oxidative Stress; Receptors, Angiotensin | 2006 |
[Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Humans; Insulin Resistance; MAP Kinase Kinase Kinase 5; Metabolic Syndrome; Oxidative Stress | 2008 |
Renin, angiotensin, and cardiac lesions.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cardiomyopathies; Catecholamines; Endothelium; Heart Ventricles; Humans; Hypertension; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Protein Biosynthesis; Rabbits; Rats; Renin | 1980 |
Occlusive and aneurysmal disease of the renal arterial circulation.
Topics: Adult; Aneurysm; Angiotensin II; Antihypertensive Agents; Arterial Occlusive Diseases; Arteriosclerosis; Blood Vessel Prosthesis; Endarterectomy; Female; Humans; Hypertension, Renovascular; Kidney; Kidney Function Tests; Male; Middle Aged; Radiography; Renal Artery; Renal Artery Obstruction; Renal Veins; Renin | 1984 |
Hypertensive cerebrovascular disease and the renin-angiotensin system.
Topics: Angiotensin II; Animals; Arteriosclerosis; Carotid Artery Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Hypertension; Intracranial Embolism and Thrombosis; Renin-Angiotensin System | 1995 |
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular System; Endothelium, Vascular; Humans; Hypertension; Hypertrophy, Left Ventricular; Kallikrein-Kinin System; Kinins; Molecular Sequence Data; Myocardial Ischemia; Nitric Oxide; Rabbits; Rats; Reperfusion Injury | 1995 |
[Molecular biology and cardiac and vascular changes in hypertension: focus on the renin-angiotensin system].
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Coronary Disease; Female; Genetic Markers; Humans; Hypertension; Hypertension, Renal; Male; Mice; Mice, Inbred DBA; Mice, Transgenic; Middle Aged; Prospective Studies; Rats; Renin-Angiotensin System; Risk Factors | 1994 |
Role of ACE inhibitors in hypertension complicated by vascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Disease; Humans; Hypertension; Peripheral Vascular Diseases | 1994 |
[Renin-angiotensin system and atherosclerosis].
Topics: Angiotensin II; Arteriosclerosis; Humans; Renin-Angiotensin System | 1993 |
Ace-inhibitors and experimental atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Captopril; Cilazapril; Endothelium, Vascular; Humans | 1993 |
Left ventricular hypertrophy in mild essential hypertension. Its progression, prediction and treatment strategy.
Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Disease Progression; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Norepinephrine | 1996 |
Modification of macrophage function and effects on atherosclerosis.
Topics: Angiotensin II; Apolipoproteins E; Arteriosclerosis; Endothelins; Foam Cells; Gelatinases; Glycation End Products, Advanced; Humans; Macrophages; Plasminogen Activators; T-Lymphocytes | 1996 |
The renin-angiotensin-aldosterone system and cardiac ischaemia.
Topics: Angina Pectoris; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Blood Flow Velocity; Coronary Vessels; Dogs; Humans; Myocardial Infarction; Myocardial Ischemia; Rats; Renin-Angiotensin System; Vasoconstriction | 1996 |
[Genetic cardiovascular risk factors].
Topics: Angiotensin II; Apolipoproteins; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Humans; Hypertension; Lipoprotein Lipase; Point Mutation; Risk Factors | 1997 |
[Anti-atherosclerotic action of angiotensin converting enzyme II. Effect on metabolism of kinin, free radical reaction, sensitivity to insulin and lipid metabolism].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Arteriosclerosis; Endothelium, Vascular; Free Radicals; Humans; Insulin; Kinins; Lipid Metabolism; Macrophages; Muscle, Smooth, Vascular; Oxidation-Reduction | 1996 |
Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Coronary Disease; Humans; Hypertension; Morbidity; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin-Angiotensin System; Risk Factors | 1996 |
Renin-angiotensin system: genes to bedside.
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cardiomyopathy, Dilated; Cardiovascular Diseases; Constriction, Pathologic; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Recurrence; Renin-Angiotensin System | 1997 |
Combination of ACE inhibitors and calcium antagonists: a logical approach.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Drug Therapy, Combination; Endothelin-1; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular | 1998 |
Angiotensin, LDL peroxidation and atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Dose-Response Relationship, Drug; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Mice; Receptors, LDL | 1998 |
[Functional role of angiotensin II predicted from the phenotypes of transgenic and knockout mice].
Topics: Angiotensin II; Animals; Arteriosclerosis; Hypertension; Mice; Mice, Knockout; Mice, Transgenic; Phenotype; Renin-Angiotensin System | 1998 |
The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System | 1998 |
The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Endothelium, Vascular; Humans; Myocardial Ischemia | 1998 |
PCR methodology applied to genetic studies of lipoprotein metabolism and atherosclerosis.
Topics: Angiotensin II; Apolipoproteins A; Apolipoproteins E; Arteriosclerosis; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Genetic Markers; Humans; Lipoproteins; Minisatellite Repeats; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Protein Isoforms; Receptors, LDL | 1998 |
Interactions among ACE, kinins and NO.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Kinins; Myocardial Ischemia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Ventricular Remodeling | 1999 |
Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors.
Topics: Angiotensin II; Animals; Apoptosis; Arteriosclerosis; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Reactive Oxygen Species | 2000 |
Treatment of hypertension in diabetes mellitus.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors | 2000 |
The multiple actions of angiotensin II in atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Blood Vessels; Humans; Lipid Peroxidation; Lipoproteins, LDL; Muscle, Smooth, Vascular; Reactive Oxygen Species; Renin | 2000 |
Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Hemodynamics; Humans; Insulin; Insulin Resistance; Models, Animal; Muscle, Smooth, Vascular; Natriuresis; Receptors, Angiotensin; Renin-Angiotensin System; Sympathetic Nervous System | 2000 |
Symposium on the etiology of hypertension--summarizing studies in 20th century. 5. Renin-angiotensin system and hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; CD36 Antigens; Gene Expression Regulation; Humans; Hypertension; Kidney; Lipoproteins, LDL; Nephrectomy; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Oxidized LDL; Renin; Renin-Angiotensin System; Scavenger Receptors, Class E; Signal Transduction; Superoxides; Transcription Factors | 2001 |
Angiotensin II and atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Humans; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2001 |
Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.
Topics: Angiotensin II; Apoptosis; Arteriosclerosis; Calcium; Endothelial Growth Factors; Endothelium, Vascular; Fas Ligand Protein; Humans; Lipoproteins, LDL; Lymphokines; Membrane Glycoproteins; Mitochondria; Models, Biological; Nitric Oxide; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Stress, Mechanical; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Angiotensin II and atherosclerosis: relevance for renal disease.
Topics: Angiotensin II; Animals; Arteriosclerosis; Biopsy, Needle; Humans; Kidney Diseases; Lipoproteins; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2001 |
The hypertension-lipid connection: insights into the relation between angiotensin II and cholesterol in atherogenesis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2002 |
Use of angiotensin II receptor blockers in animal models of atherosclerosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteriosclerosis; Cholesterol, LDL; Disease Models, Animal; Endothelium, Vascular; Hypertension; Nitric Oxide; Renin-Angiotensin System | 2002 |
The role of the renin-angiotensin system in the development of cardiovascular disease.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertrophy, Left Ventricular; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |
Novel mechanisms linking angiotensin II and early atherogenesis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Humans; Losartan; Models, Cardiovascular; Monocytes; Phenotype | 2000 |
Angiotensin II as a pro-inflammatory mediator.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Adhesion; Chemotaxis; Cytokines; Endothelium, Vascular; Growth Substances; Humans; Inflammation; Macrophages; Muscle, Smooth, Vascular; NF-kappa B; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin | 2002 |
Role of hypertension in atherosclerosis and cardiovascular disease.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Blood Platelets; Capillary Permeability; Cardiomegaly; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Endothelium; Histamine; Humans; Hypertension; Lipids; Lysosomes; Muscle, Smooth; Renin; Serotonin; Thrombosis | 1976 |
The morphological basis for altered endothelial permeability in artherosclerosis.
Topics: Angiotensin II; Animals; Antigen-Antibody Complex; Arteries; Arteriosclerosis; Biogenic Amines; Carbon Monoxide; Cell Membrane Permeability; Cholesterol; Endothelium; Fatty Acids; Hypertension; Rheology | 1977 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1979 |
[Pathophysiology of renal hypertension (author's transl)].
Topics: Aldosterone; Angiotensin II; Arteriosclerosis; Blood Pressure; Catecholamines; Child; Extracellular Space; Glomerulonephritis; Hematoma; Hemodynamics; Humans; Hypertension, Malignant; Hypertension, Renal; Infarction; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Neoplasms; Male; Nephrectomy; Pulse; Renin; Sodium; Water-Electrolyte Balance | 1975 |
Cardioprotection and ACE inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Prognosis | 1992 |
ACE-inhibitors and atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats | 1992 |
Regulation of large cerebral arteries and cerebral microvascular pressure.
Topics: Angiotensin II; Arterioles; Arteriosclerosis; Blood Pressure; Brain; Cerebral Arteries; Cerebrovascular Circulation; Humans; Hypertension; Ischemic Attack, Transient; Microcirculation; Sympathetic Nervous System; Thromboxanes; Vascular Resistance; Vasopressins | 1990 |
Large conduit arteries in hypertension: role of the vascular renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Arteriosclerosis; Hemodynamics; Humans; Hypertension; Renin-Angiotensin System | 1988 |
Renal arterial hypertension.
Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Biopsy; Humans; Hypertension, Renal; Kidney; Kidney Function Tests; Radiography; Radioisotope Renography; Radionuclide Imaging; Renal Artery; Renal Artery Obstruction; Renin | 1968 |
[On the pathogenesis of the so-called malignant hypertension].
Topics: Adrenal Gland Diseases; Aldosterone; Angiotensin II; Arteriosclerosis; Humans; Hypertension, Malignant; Renin | 1968 |
Arterial hypertension in retrospect.
Topics: Adrenal Glands; Angiotensin II; Arteriosclerosis; Blood Flow Velocity; Blood Pressure; Cardiac Output; Humans; Hypertension; Models, Biological; Muscle, Smooth; Nervous System; Plasma Volume; Prostaglandins; Renal Artery; Vascular Resistance; Water-Electrolyte Balance | 1974 |
4 trial(s) available for angiotensin ii and Arteriosclerosis
| Article | Year |
|---|---|
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Atenolol; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Artery, Common; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Laser-Doppler Flowmetry; Male; Manometry; Middle Aged; Models, Cardiovascular; Tetrazoles; Ultrasonography | 2002 |
A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery.
Topics: Aged; Aldosterone; Angiotensin II; Aorta, Abdominal; Aortic Diseases; Arginine Vasopressin; Arteriosclerosis; Atrial Natriuretic Factor; Blood Vessel Prosthesis; Dopamine; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Potassium; Prospective Studies; Renal Plasma Flow, Effective; Sodium | 1995 |
[Effect of anti-atherosclerotic diet with polyunsaturated fatty acids omega-3 from linseed oil on dynamics of natural antibodies to bradykinin and angiotensin II in blood serum of patients with cardiovascular diseases].
Topics: Adult; Angiotensin II; Antibodies; Arteriosclerosis; Bradykinin; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Humans; Hyperlipoproteinemias; Hypertension; Linseed Oil; Male; Middle Aged; Myocardial Ischemia | 1998 |
Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Brachial Artery; Endothelium, Vascular; Female; Femoral Artery; Humans; Hyperemia; Losartan; Male; Middle Aged; Nitroprusside; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Single-Blind Method; Time Factors; Vascular Resistance; Vasodilation; Vasodilator Agents | 2000 |
122 other study(ies) available for angiotensin ii and Arteriosclerosis
| Article | Year |
|---|---|
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2008 |
[Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
Topics: Angiotensin II; Animals; Aorta, Abdominal; Apolipoproteins E; Arteriosclerosis; Diet; Dietary Fats; Disease Models, Animal; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout | 2010 |
Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
Topics: Acetylcysteine; Angiotensin II; Animals; Arteriosclerosis; Cells, Cultured; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Indican; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Up-Regulation | 2012 |
Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation.
Topics: Angiotensin II; Animals; Apoptosis; Arteriosclerosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Count; Cell Division; Constriction, Pathologic; DNA; Femoral Artery; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tunica Intima; Vascular Patency | 2002 |
Lysophosphatidylcholine potentiates the mitogenic effect of various vasoactive compounds on rabbit aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Arteriosclerosis; Cells, Cultured; DNA; Drug Synergism; Endothelin-1; Hydrogen Peroxide; Lysophosphatidylcholines; Mitogens; Muscle, Smooth, Vascular; Rabbits; Serotonin; Thromboxane A2; Thymidine; Type C Phospholipases; Urotensins; Vasoconstrictor Agents | 2002 |
Cardiovascular responses to angiotensin II in atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cardiac Output, Low; Diet, Atherogenic; Female; Hypertension; Lipids; Male; Rabbits; Vasoconstrictor Agents | 2002 |
Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Arteriosclerosis; Cell Adhesion Molecules; Chemokines; Cyclooxygenase 2; Down-Regulation; Gene Expression Regulation; Isoenzymes; Male; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors | 2002 |
Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Blood Pressure; Carotid Arteries; Collagen; Drug Administration Schedule; Elasticity; Elastin; Endothelium, Vascular; Male; Mice; Mice, Knockout; Nitroprusside | 2002 |
Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; In Situ Hybridization; Interleukin-6; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2003 |
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Cholesterol; Doxycycline; Hyperlipidemias; Lipoproteins; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Mutant Strains | 2003 |
Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.
Topics: Aneurysm; Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Dissection; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL | 2003 |
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Cell Movement; Cell Survival; Chemokine CCL2; Cytokines; Gene Expression Regulation; Leukocytes; Macrophages; Mice; Mice, Inbred C57BL; Osteopontin; Receptors, CCR2; Receptors, Chemokine; RNA, Messenger; Sialoglycoproteins | 2003 |
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Chemokine CCL2; Chemokines; Cytokines; Disease Progression; Gene Expression Regulation; Gene Targeting; Humans; Hyperlipoproteinemia Type II; Imidazoles; Inflammation; Inflammation Mediators; Injections, Intramuscular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Olmesartan Medoxomil; Random Allocation; Recombinant Fusion Proteins; Sequence Deletion; Single-Blind Method; Tetrazoles | 2004 |
Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Female; Gonadal Steroid Hormones; Male; Mice; Mice, Inbred C57BL; Orchiectomy; Ovariectomy; Sex Characteristics | 2004 |
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides | 2004 |
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis.
Topics: Aged; Angiotensin II; Arteriosclerosis; Biphenyl Compounds; Blotting, Western; Carotid Stenosis; Carrier Proteins; Culture Techniques; Female; Glycoproteins; Humans; Immunohistochemistry; Irbesartan; Male; Membrane Glycoproteins; Middle Aged; Osteopontin; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Tetrazoles; Up-Regulation | 2004 |
Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Catheterization; Chemokine CCL2; Chemotaxis; Cholesterol; Cytokines; Diet, Atherogenic; DNA, Complementary; Drug Evaluation, Preclinical; Genetic Therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iliac Artery; Immunoglobulin G; Immunoglobulin M; Inflammation; Macaca fascicularis; Male; Peptidyl-Dipeptidase A; Phenotype; Pravastatin; Random Allocation; Renin; Transfection | 2004 |
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Coronary Artery Disease; Fibrosis; Hypercholesterolemia; Hypertension, Renovascular; Ligation; Mice; Mice, Knockout; Nephrectomy; Renal Artery; Renin; Renin-Angiotensin System; Rupture, Spontaneous; Th1 Cells; Th2 Cells; Vasculitis | 2004 |
Hypertension: a novel regulator of adaptive immunity in atherosclerosis?
Topics: Adaptation, Physiological; Angiotensin II; Animals; Apolipoproteins E; Arteriosclerosis; Collagen; Disease Models, Animal; Fibrosis; Humans; Hypertension; Hypertension, Renovascular; Inflammation; Ligation; Lipids; Macrophages; Mice; Nephrectomy; Phenotype; Rabbits; Renal Artery; Renin-Angiotensin System; Th1 Cells; Th2 Cells | 2004 |
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Bone Marrow; Bone Marrow Transplantation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Monocytes; Receptors, CCR2; Receptors, Chemokine | 2004 |
Angiotensin II amplifies macrophage-driven atherosclerosis.
Topics: Angiotensin II; Animals; Apolipoproteins E; Arteriosclerosis; Bone Marrow Transplantation; Cell Movement; Cholesterol; Disease Models, Animal; Female; Infusion Pumps, Implantable; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL | 2004 |
Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques.
Topics: Actins; Aged; Angiotensin II; Arteriosclerosis; Brain Ischemia; Carotid Stenosis; Female; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Platelet Endothelial Cell Adhesion Molecule-1; Stroke | 2004 |
Factor XIIIA (cross)links AT1 receptors to atherosclerosis.
Topics: Angiotensin II; Arteriosclerosis; Factor XIIIa; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2004 |
Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Arteriosclerosis; Dimerization; Factor XIIIa; Glutamine; Humans; Mice; Monocytes; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction | 2004 |
Losartan inhibited expression of matrix metalloproteinases in rat atherosclerotic lesions and angiotensin II-stimulated macrophages.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Losartan; Macrophages, Peritoneal; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Inbred WKY; RNA, Messenger | 2004 |
Potential anti-atherogenic cell action of the naturally occurring 4-O-methyl derivative of gallic acid on Ang II-treated macrophages.
Topics: Angiotensin II; Arteriosclerosis; Base Sequence; CD36 Antigens; Cell Line; DNA Primers; Gallic Acid; Humans; Macrophages; Receptors, Angiotensin; RNA, Messenger; Superoxides | 2004 |
Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Apolipoproteins E; Arteriosclerosis; Cell Adhesion Molecules; Chemokines; Enalapril; Endothelium; Gene Expression; Male; Mice; Mice, Knockout; PPAR alpha; PPAR gamma; RNA, Messenger; Up-Regulation; Vasculitis | 2005 |
Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin III; Angiotensinogen; Animals; Aortic Diseases; Arteriosclerosis; Chemokine CCL2; Chickens; Diet, Atherogenic; Female; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, LDL; Renin-Angiotensin System; RNA, Messenger | 2004 |
Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Topics: Aldosterone; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Blood Pressure; Body Weight; Cholesterol; Diuretics; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Organ Size; Spironolactone | 2005 |
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Biphenyl Compounds; Calcium; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cholesterol, LDL; Dose-Response Relationship, Drug; Endothelin-1; Female; Fibroblasts; Heterozygote; Humans; Hyperlipoproteinemia Type II; Irbesartan; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Middle Aged; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta | 2005 |
Double trouble for type 1 angiotensin receptors in atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Dimerization; Factor XIIIa; Humans; Hyperlipidemias; Hypertension; Mice; Monocytes; Receptor, Angiotensin, Type 1; Transglutaminases | 2005 |
Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Arteriosclerosis; Cells, Cultured; Enzyme Activation; Estradiol; Female; Imidazoles; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Ovariectomy; Oxidative Stress; Tetrazoles | 2005 |
Mast cell chymase in the ischemic kidney of severe unilateral renovascular hypertension.
Topics: Angiography, Digital Subtraction; Angiotensin I; Angiotensin II; Arteriosclerosis; Captopril; Chymases; Female; Humans; Hyperaldosteronism; Hypertension, Renovascular; Ischemia; Kidney; Mast Cells; Middle Aged; Nephrectomy; Renal Artery; Renal Artery Obstruction; Renal Veins; Renin; Renin-Angiotensin System; Serine Endopeptidases; Smoking | 2005 |
Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Female; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sinus of Valsalva | 2005 |
Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; DNA-Binding Proteins; Gene Expression Regulation; Humans; Inflammation; Interleukin-18; Interleukin-18 Receptor alpha Subunit; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Receptor, Angiotensin, Type 1; Receptors, Interleukin; Receptors, Interleukin-18; STAT3 Transcription Factor; Trans-Activators; Transcriptional Activation | 2005 |
Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Arteriosclerosis; Female; Male; Mice; Mice, Knockout; Renin-Angiotensin System; Sodium, Dietary | 2005 |
Diminution of angiotensin II-induced contraction of the abdominal aorta isolated from Watanabe heritable hyperlipidemic rabbits.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Arteriosclerosis; Body Weight; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Hyperlipidemias; Imidazoles; In Vitro Techniques; Lipids; Male; Nitroarginine; Pyridines; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Does the AT2-receptor mediate anti-atherosclerotic actions?
Topics: Angiotensin II; Animals; Apolipoproteins; Arteriosclerosis; Blood Pressure; Cholesterol, Dietary; Imidazoles; Male; Mice; Mice, Knockout; Pyridines; Receptor, Angiotensin, Type 2; Vasoconstrictor Agents | 2005 |
Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE-/- mice.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Blood Pressure; Cholesterol, Dietary; Imidazoles; Immunohistochemistry; Mice; Mice, Knockout; Pyridines; Receptor, Angiotensin, Type 2; Vasoconstrictor Agents | 2005 |
Essential role of Smad3 in angiotensin II-induced vascular fibrosis.
Topics: Adult; Aged; Angiotensin II; Aorta; Arteriosclerosis; Cells, Cultured; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hypertension; Male; MAP Kinase Signaling System; Middle Aged; Muscle, Smooth, Vascular; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad2 Protein; Smad3 Protein | 2006 |
Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Body Weight; Cholesterol; Connexin 43; Losartan; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rabbits; Ramipril; RNA, Messenger | 2006 |
Positive correlation between chymase-like angiotensin II-forming activity in mononuclear cells and serum cholesterol level.
Topics: Angiotensin II; Arteriosclerosis; Cholesterol; Chymases; Humans; Hypertension; Leukocytes, Mononuclear; Middle Aged; Risk Factors; Smoking | 2007 |
Saralasin infusion in screening patients for renovascular hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Arteriosclerosis; Blood Pressure; Child; Female; Fibromuscular Dysplasia; Humans; Hypertension, Renal; Hypertension, Renovascular; Male; Middle Aged; Renal Artery Obstruction; Renin; Saralasin; Urography | 1980 |
Atherosclerosis in uremia: a longitudinal study.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cholesterol; Chronic Disease; Humans; Hyperlipidemias; Kidney Transplantation; Lipoproteins; Renal Dialysis; Transplantation, Homologous; Triglycerides; Uremia | 1980 |
[The arterial endothelium--present state of knowledge].
Topics: Acetates; Angiotensin II; Animals; Arteries; Arteriosclerosis; Carbon Monoxide; Cyanides; Endothelium; Epinephrine; Humans; Hypertension; Lipoproteins; Molecular Weight; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits | 1982 |
Baroreflex sensitivity in rabbits during the development of experimental renal hypertension and medial sclerosis.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Blood Pressure; Dose-Response Relationship, Drug; Hypertension, Renal; Injections, Intravenous; Muscle, Smooth, Vascular; Phenylephrine; Pressoreceptors; Pulse; Rabbits; Reflex; Time Factors | 1980 |
Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling.
Topics: Angiotensin II; Animals; Arteriosclerosis; Atrial Natriuretic Factor; Base Sequence; Cattle; Cell Division; Cells, Cultured; Endothelium, Vascular; Gene Expression Regulation; Guanylate Cyclase; Hypertension; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; RNA; Stimulation, Chemical | 1994 |
Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Aorta; Arteriosclerosis; Biphenyl Compounds; Cell Division; Cells, Cultured; Disease Progression; DNA; Humans; Imidazoles; Kinetics; Losartan; Muscle, Smooth, Vascular; Receptors, Angiotensin; Renin-Angiotensin System; Stimulation, Chemical; Tetrazoles; Thymidine; Tritium | 1995 |
Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine.
Topics: Angiotensin II; Animals; Aorta; Arteriosclerosis; Cholestanols; Cholesterol; Cholic Acid; Cholic Acids; Endothelium, Vascular; Homocysteine; Hypertension; Hypolipidemic Agents; Male; Methionine; Methylthiouracil; Microscopy, Electron; Mitochondria; Rats; Rats, Inbred SHR; Rats, Wistar; Tunica Intima; Vasoconstrictor Agents | 1996 |
Angiotensin II increases monocyte binding to endothelial cells.
Topics: Angiotensin II; Animals; Aorta; Arteriosclerosis; Cell Adhesion; Cell Division; Cells, Cultured; E-Selectin; Endothelium, Vascular; HL-60 Cells; Humans; Intercellular Adhesion Molecule-1; Kinetics; Lipopolysaccharides; Lipoproteins, LDL; Monocytes; Rabbits; Time Factors; Vascular Cell Adhesion Molecule-1 | 1996 |
Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Carotid Arteries; Disease Models, Animal; Endothelium, Vascular; Hemodynamics; In Vitro Techniques; Indoles; Nitric Oxide; Peptidyl-Dipeptidase A; Perindopril; Rabbits; Serotonin; Vasoconstriction; Vasodilation | 1996 |
The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriosclerosis; Cell Division; Cholesterol; Cholesterol, Dietary; Chromatography, High Pressure Liquid; Enalapril; Imidazoles; Lipoproteins; Oligonucleotide Probes; Polymerase Chain Reaction; Pyridines; Rabbits; Random Allocation; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Spectrophotometry | 1996 |
Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriosclerosis; Blood Pressure; Cholesterol, Dietary; Enalapril; Male; Peptidyl-Dipeptidase A; Rabbits | 1997 |
Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Aorta, Thoracic; Arteriosclerosis; Base Sequence; Chymases; Dogs; Enzyme Induction; Glycosylation; Humans; Macaca fascicularis; Male; Molecular Sequence Data; Rats; RNA, Messenger; Sequence Homology; Serine Endopeptidases | 1997 |
[Physiopathology of angiotensin II and vascular lesion].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Humans; Hypertension; Losartan | 1997 |
[Therapy of endothelial dysfunction with ACE inhibitors].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Endothelium, Vascular; Humans | 1997 |
Inhibitory action of silibinin on low density lipoprotein oxidation.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Division; Cells, Cultured; Copper; Female; Humans; Hypolipidemic Agents; Lipoproteins, LDL; Muscle, Smooth, Vascular; Oxidation-Reduction; Rats; Silymarin; Thymidine | 1998 |
Evidence that macrophages in atherosclerotic lesions contain angiotensin II.
Topics: Angiotensin II; Animals; Arteriosclerosis; Atherectomy, Coronary; Humans; Macaca fascicularis; Macrophages; Muscle, Smooth, Vascular | 1998 |
Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arteriosclerosis; Autoradiography; Cholesterol, Dietary; Gene Expression; Hypercholesterolemia; Immunohistochemistry; Male; Norepinephrine; Polymerase Chain Reaction; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA-Directed DNA Polymerase; RNA, Messenger; Tissue Distribution | 1998 |
Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
Topics: Angiotensin II; Arteriosclerosis; Cell Division; Cells, Cultured; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Signal Transduction | 1999 |
Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Binding, Competitive; Cell Separation; Consensus Sequence; Humans; Inflammation; Losartan; Lymphocytes; Monocytes; NF-kappa B; NF-kappa B p50 Subunit; Oligonucleotides; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 1999 |
Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta.
Topics: Aged; Aged, 80 and over; Angiotensin II; Aorta; Aortic Aneurysm; Arteriosclerosis; Chymases; Female; Humans; Immunohistochemistry; Male; Middle Aged; Peptidyl-Dipeptidase A; Reference Values; Serine Endopeptidases | 1999 |
Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteriosclerosis; Carotid Artery Injuries; Carotid Artery, Common; Catheterization; Cell Division; Cell Movement; Cells, Cultured; Glycine; Hyperplasia; Male; Mitogen-Activated Protein Kinase 1; Muscle, Smooth, Vascular; Protein Kinase C; Proto-Oncogene Proteins p21(ras); Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Tetrazoles | 1999 |
Angiotensin induces inflammatory activation of human vascular smooth muscle cells.
Topics: Angiotensin II; Arteriosclerosis; Cells, Cultured; Humans; Interleukin-6; Muscle, Smooth, Vascular; NF-kappa B; Peptidyl-Dipeptidase A; Pyrrolidines; Receptors, Angiotensin; RNA, Messenger; Thiocarbamates; Vasculitis | 1999 |
Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages.
Topics: Angiotensin II; Arteriosclerosis; Binding Sites; Cell Differentiation; Cytokines; Humans; Macrophages; Monocytes; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Tumor Cells, Cultured; Up-Regulation | 1999 |
Human mesangial cells express inducible macrophage scavenger receptor.
Topics: Angiotensin II; Arteriosclerosis; Carbocyanines; Carcinogens; Cell Adhesion Molecules; Cell Line; Cholesterol, LDL; DNA Probes; Dose-Response Relationship, Drug; Fluorescent Dyes; Foam Cells; Gene Expression Regulation; Genes, Reporter; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Mutagenesis; Plasmids; Prolactin; Promoter Regions, Genetic; Receptors, Immunologic; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Vasoconstrictor Agents | 1999 |
Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery.
Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Cell Count; Cell Division; Cells, Cultured; Coronary Vessels; Female; Humans; Muscle, Smooth, Vascular; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents | 1999 |
Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cells, Cultured; Gene Expression; Hypertension; Immunohistochemistry; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; Vascular Cell Adhesion Molecule-1 | 1999 |
Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriosclerosis; Biphenyl Compounds; Cholesterol, Dietary; Female; Imidazoles; Indoles; Macaca fascicularis; Male; Peptidyl-Dipeptidase A | 1999 |
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Arteriosclerosis; Cell Line; Cholesterol; Disease Models, Animal; DNA Primers; Gene Expression; Humans; Hydroxymethylglutaryl CoA Reductases; Injections, Intraperitoneal; Macrophages, Peritoneal; Mice; Monocytes; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Vasoconstrictor Agents | 1999 |
Cyclic strain stimulates monocyte chemotactic protein-1 mRNA expression in smooth muscle cells.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Movement; Cells, Cultured; Chemokine CCL2; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Monocytes; Muscle, Smooth, Vascular; Naphthalenes; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Rats; RNA, Messenger; Stress, Mechanical | 1999 |
Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia.
Topics: Aged; Angiotensin II; Arteriosclerosis; Cholesterol; Cholesterol, LDL; Chymases; Female; Humans; Hypercholesterolemia; Immunohistochemistry; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases; Thoracic Arteries | 2000 |
Vascular response to angiotensin II in atherosclerosis: role of the baroreflex.
Topics: Angiotensin II; Animals; Arteriosclerosis; Baroreflex; Blood Pressure; Cholesterol; Cholesterol, Dietary; Diastole; Female; Heart Rate; Hemodynamics; Lipids; Male; Rabbits; Systole; Tissue Distribution | 2000 |
Angiotensin II, atherosclerosis, and aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Mice; Reactive Oxygen Species | 2000 |
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Female; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL | 2000 |
Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Blood Pressure; Cholesterol; Infusions, Intravenous; Lipoproteins, LDL; Mice; Mice, Inbred C57BL; Severity of Illness Index; Vasoconstrictor Agents | 1999 |
Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Biological Transport, Active; CD36 Antigens; Gene Expression; Humans; Hypercholesterolemia; In Vitro Techniques; Lipoproteins, LDL; Losartan; Macrophages; Monocytes; Oxidation-Reduction; RNA, Messenger | 2000 |
Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis.
Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Chymases; Cricetinae; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Mesocricetus; Renin; Renin-Angiotensin System; Serine Endopeptidases | 2000 |
Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Angiotensin II; Arteriosclerosis; Blood Pressure; Female; Fibromuscular Dysplasia; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Predictive Value of Tests; Renal Artery Obstruction; Renin; Renin-Angiotensin System; Technetium Tc 99m Pentetate; Time; Time Factors | 2000 |
Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Hypertension; Mice; Mice, Knockout; Norepinephrine | 2001 |
[Angiotensin converting enzyme-angiotensin II system, atherosclerosis, and angiotensin-converting enzyme inhibitors].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Humans; Peptidyl-Dipeptidase A | 2000 |
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Cell Line; Cell Movement; CSK Tyrosine-Protein Kinase; Cytoskeletal Proteins; Enzyme Induction; Enzyme Inhibitors; Humans; Isoenzymes; Losartan; Monocytes; Paxillin; Phosphopeptides; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; src-Family Kinases | 2001 |
Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Arteriosclerosis; Chemokine CCL2; Diet, Atherogenic; Hyperlipidemias; Losartan; Male; P-Selectin; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2001 |
LDL cholesterol angiotensin II interactions in atherosclerosis.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cholesterol, LDL; Female; Humans; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 2001 |
Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; CD36 Antigens; Cell Adhesion; Cell Differentiation; Cells, Cultured; Cholesterol, Dietary; Disease Models, Animal; Humans; Hypertension; Immunohistochemistry; Losartan; Macrophages; Male; Membrane Proteins; Mice; Mice, Knockout; Monocytes; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; RNA, Messenger; Scavenger Receptors, Class A; Scavenger Receptors, Class B; Stress, Mechanical; Tetradecanoylphorbol Acetate; Transcription Factors | 2001 |
[Effects of anti-atherosclerotic low-sodium diet on dynamics of natural antibodies to angiotensin II, bradykinin and vasopressin in blood of patients with hypertension and obesity].
Topics: Adult; Angiotensin II; Arteriosclerosis; Bradykinin; Diet, Sodium-Restricted; Female; Humans; Hypertension; Immunoenzyme Techniques; Male; Middle Aged; Obesity; Vasopressins | 2001 |
Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Arteriosclerosis; Blotting, Northern; Cattle; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibronectins; Imidazoles; Losartan; Male; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thrombospondin 1 | 2001 |
Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.
Topics: Angiotensin II; Animals; Antibodies; Apolipoproteins E; Arteriosclerosis; CD36 Antigens; Cells, Cultured; Dose-Response Relationship, Drug; Foam Cells; Injections; Interleukin-6; Lipoproteins, LDL; Losartan; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Knockout; Receptors, Interleukin-6; RNA, Messenger | 2001 |
Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Arteriosclerosis; Drug Synergism; Female; Imidazoles; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Severity of Illness Index | 2001 |
The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Humans; Models, Biological; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Risk Factors | 2002 |
Introduction: the hemodynamic and vascular effects of angiotensin II: managing the consequences.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Humans; Renin-Angiotensin System | 2002 |
Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Arteriosclerosis; Blotting, Western; Cholesterol; Diet, Atherogenic; Gene Expression Regulation; Hypercholesterolemia; Immunohistochemistry; Losartan; Male; Matrix Metalloproteinase 1; NF-kappa B; Rabbits; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Tunica Intima; Tunica Media | 2002 |
Anti-atherosclerotic efficacy of olmesartan.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arteriosclerosis; Biomarkers; Cholesterol; Cholesterol, Dietary; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Imidazoles; In Vitro Techniques; Inflammation; Lipids; Macaca fascicularis; Male; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome | 2002 |
Lipid metabolism.
Topics: Angiotensin II; Arteriosclerosis; Cholesterol, LDL; Gene Expression Regulation; Hypertension; Interleukin-6; Lipid Metabolism; Macrophages | 2002 |
Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Division; Cells, Cultured; Chromans; Depression, Chemical; DNA; Growth Substances; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thiazoles; Thiazolidinediones; Troglitazone; Tyrosine | 2002 |
Endothelial function and oxidative stress in renovascular hypertension.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcholine; Adult; Angioplasty; Angiotensin II; Antioxidants; Arteriosclerosis; Ascorbic Acid; Biomarkers; Blood Pressure; Deoxyguanosine; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fibromuscular Dysplasia; Forearm; Humans; Hypertension, Renovascular; Isosorbide Dinitrate; Lipoproteins; Male; Matched-Pair Analysis; Middle Aged; Oxidative Stress; Regional Blood Flow; Renal Artery; Vasodilation; Vasodilator Agents | 2002 |
Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II.
Topics: Angiogenesis Inducing Agents; Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Blood Vessels; Cells, Cultured; Cysteine-Rich Protein 61; Growth Substances; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Transcriptional Activation; Up-Regulation | 2002 |
[New concepts on the pathogenesis of atherosclerosis and its practical aspects].
Topics: Angiotensin II; Animals; Arteries; Arteriosclerosis; Cholesterol; Diet, Atherogenic; Endothelium; Haplorhini; Humans; Hypertension; Platelet Aggregation; Rabbits; Smoking; Takayasu Arteritis | 1976 |
Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders.
Topics: Actomyosin; Angiotensin II; Animals; Arteries; Arteriosclerosis; Bucladesine; Carbon; Chickens; Cyclic AMP; Depression, Chemical; Diethylstilbestrol; Dogs; Endothelium; Estrogens, Conjugated (USP); Hypertension; Macaca mulatta; Phagocytosis; Phosphodiesterase Inhibitors; Phthalazines; Progesterone; Pyridinolcarbamate; Rabbits; Rats | 1975 |
Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Female; Humans; Hypertension, Renal; Hypertension, Renovascular; Kidney; Male; Regional Blood Flow; Renal Artery; Renal Artery Obstruction; Renal Veins; Renin; Saralasin | 1978 |
[Renovascular hypertension].
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Child; Female; Furosemide; Humans; Hypertension, Renal; Male; Middle Aged; Renal Artery Obstruction; Renin | 1977 |
Autoradiographic localization of angiotensin-converting enzyme and angiotensin II binding sites in early atheroma-like lesions in rabbit arteries.
Topics: Angiotensin II; Animals; Arteriosclerosis; Autoradiography; Binding Sites; Carotid Arteries; Iodine Radioisotopes; Peptidyl-Dipeptidase A; Rabbits | 1991 |
Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Matrix; Glycoconjugates; Hypertension; Kinetics; Muscle Development; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR | 1990 |
Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; In Vitro Techniques; Isradipine; Norepinephrine; Phenylephrine; Pyridines; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 1988 |
Injury and repair in arterial tissue: contraction and blebbing of endothelial cells in atherogenesis and thrombogenesis and abnormal secretion of sex hormone in Takayasu's disease.
Topics: Adolescent; Adult; Angiotensin II; Animals; Aorta; Aortic Arch Syndromes; Arteries; Arteriosclerosis; Cholesterol; Endothelium; Epinephrine; Estrogens; Female; Fluorescent Antibody Technique; gamma-Globulins; Gonadal Steroid Hormones; Humans; Lipoproteins, LDL; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Pregnanediol; Rabbits; Regeneration; Takayasu Arteritis; Thrombosis; Vascular Diseases | 1974 |
Conservative treatment of gangrene using mineralocorticoid-induced moderate hypertension.
Topics: Adult; Aged; Angiotensin II; Arteriosclerosis; Desoxycorticosterone; Exercise Therapy; Female; Fludrocortisone; Gangrene; Humans; Hypertension; Leg Ulcer; Male; Middle Aged; Smoking; Sodium Chloride; Thromboangiitis Obliterans | 1968 |
Changes in the carotid pulse which occur with age and hypertension.
Topics: Adult; Aging; Amyl Nitrite; Angiotensin II; Arteriosclerosis; Blood Pressure; Carotid Arteries; Electrocardiography; Heart Rate; Hemodynamics; Humans; Hypertension; Isoproterenol; Methoxamine; Phonocardiography; Pulse; Trimethaphan | 1966 |
Myocardial function in patients with coronary artery disease.
Topics: Adolescent; Adult; Aged; Angiocardiography; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Function Tests; Heart Ventricles; Humans; Male; Middle Aged; Stress, Physiological | 1969 |
[Plasma renin activity in peripheral venous blood under various stimulation conditions].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Arteriosclerosis; Blood Pressure; Creatinine; Glomerulonephritis; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Nephritis; Pheochromocytoma; Plasma; Pyelonephritis; Radioisotope Dilution Technique; Renal Artery; Renin; Urography; Veins | 1969 |
Renal artery stenosis and hypertension. Observations on current status of therapy from a study of 115 patients.
Topics: Adult; Age Factors; Angiotensin II; Aortography; Arteriosclerosis; Biopsy; Blood Pressure; Diabetes Complications; Female; Humans; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Nephrectomy; Renal Artery Obstruction; Renin; Urography | 1969 |
End-vessel reactivity and capillary clearance in diabetes mellitus.
Topics: Angiotensin II; Arteriosclerosis; Capillaries; Capillary Permeability; Diabetes Mellitus; Humans; Injections, Intradermal; Skin Tests; Sodium Chloride; Vasomotor System; Wound Healing | 1970 |
[Results of the intradermal hypertension test and Hines-Brown cooling test in various types of arterial hypertension].
Topics: Adult; Aged; Angiotensin II; Arteriosclerosis; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged | 1970 |
Induced hypertension in the treatment of the ischaemic foot.
Topics: Aged; Angiotensin II; Arteriosclerosis; Blood Pressure; Foot; Foot Diseases; Humans; Hypertension; Injections, Intravenous; Ischemia; Middle Aged; Plethysmography; Regional Blood Flow; Sympathectomy | 1970 |
Prolonged measurement of 133 Xenon disappearance from subcutaneous tissue of the foot.
Topics: Angiotensin II; Arteriosclerosis; Connective Tissue; Foot; Gangrene; Half-Life; Histamine; Hot Temperature; Humans; Ischemia; Posture; Radioisotope Dilution Technique; Radioisotopes; Regional Blood Flow; Skin; Skin Temperature; Temperature; Tibial Nerve; Time Factors; Xenon | 1971 |
[Hypertension and hypertensive syndromes].
Topics: Adult; Aldosterone; Angiotensin II; Arteriosclerosis; Glomerulonephritis; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Renin; Sodium | 1971 |
Heart attacks: possible risk factor.
Topics: Adrenal Cortex Hormones; Angiotensin II; Arteriosclerosis; Blood Vessels; Humans; Hypertension; Hypertension, Malignant; Myocardial Infarction; Renin | 1972 |
[Renovascular hypertension: pathophysiology and operative indications].
Topics: Adult; Age Factors; Aneurysm; Angiotensin II; Aorta, Abdominal; Aortography; Arteriosclerosis; Blood Pressure Determination; Collateral Circulation; Creatinine; Female; Humans; Hypertension, Renal; Ischemia; Kidney; Male; Renal Artery; Renin; Sodium | 1972 |
Comparison of isometric exercise and angiotensin infusion as stress test for evaluation of left ventricular function.
Topics: Angiotensin II; Arteriosclerosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Coronary Disease; Evaluation Studies as Topic; Heart; Heart Diseases; Heart Rate; Humans; Myocardium; Oxygen Consumption; Physical Exertion; Stress, Physiological | 1973 |
Arterial endothelial permeability and vascular disease. The "trap door" effect.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Arteries; Arteriosclerosis; Blood Platelets; Bradykinin; Capillary Permeability; Endothelium; Female; Intercellular Junctions; Lipoproteins; Macromolecular Substances; Microscopy, Electron; Norepinephrine; Rats; Serotonin; Thrombosis; Vascular Diseases | 1973 |
Decreased vasoconstrictor response to angiotensin II in the presence of vascular stenosis.
Topics: Acetylcholine; Angiotensin II; Animals; Arteriosclerosis; Blood Flow Velocity; Dogs; Femoral Artery; Vascular Resistance; Vasoconstrictor Agents | 1974 |
Plasma free fatty acid and acute vascular injury.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Angiotensin II; Animals; Aorta; Arteriosclerosis; Cholesterol; Epinephrine; Fatty Acids, Nonesterified; Heparin; Injections, Intravenous; Oleic Acids; Placebos; Rabbits | 1973 |
[Therapeutic progress in the area of arterial hypertension].
Topics: Adult; Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Belgium; Catecholamines; Coronary Disease; Female; Humans; Hypertension; Male; Middle Aged; Prognosis; Renin; Sympathetic Nervous System | 1974 |